Related by context. All words. (Click for frequent words.) 66 XTEN 65 generation purine nucleoside 65 Anticalins R 64 PEGylated interferon 64 PDE4 inhibitor 64 mealtime insulin 64 Enhanze Technology 63 intradermal injection 63 R#/MEM 63 glycosylation profile 63 Orally administered 63 busulfan 62 rxRNA 62 orally inhaled 62 liposomal formulation 62 hPTH #-# 62 PNP inhibitor 62 somatostatin analogue 62 ARIKACE ™ 62 alkylating agent 62 topoisomerase II inhibitor 62 siRNAs targeting 62 Factor IX 62 MAGE A3 ASCI 62 HCD# [002] 62 subcutaneously injected 62 orally administered inhibitor 61 Gamunex C 61 vidofludimus 61 PN# [001] 61 alemtuzumab MS 61 vapreotide acetate 61 subcutaneous formulation 61 Nanobodies 61 proprietary polysaccharide 61 novel VDA molecule 61 Panzem R NCD 61 small molecule Hedgehog 61 Urocidin TM 61 morpholino 61 urate oxidase 61 aurora kinase 60 intranasal formulation 60 Enkephalin 60 HuMax TAC 60 plasmid encoding 60 mertansine 60 forodesine 60 non nucleoside 60 hyaluronidase enzyme 60 NanoTab 60 prostanoid 60 HYLENEX recombinant 60 recombinant adeno associated 60 octreotide acetate 60 Preclinical studies suggest 60 intradermal injections 60 pharmacodynamic PD 60 Octreolin 60 peptidomimetic 60 interleukin IL -# 60 Solulin 60 AAG geldanamycin analog 60 immunotherapeutic agent 60 IFN Beta CTP 60 Trofex 60 targeted radiotherapeutic 60 induced phosphorylation 60 uricase 60 SPRIX ® 60 PEGylated Fab fragment 60 immune modulating 60 GnRH antagonist 60 Prodarsan ® 60 effector function 60 adenosine injection 60 Spiegelmer ® 60 aplindore 60 peptide antigens 60 Alfacell proprietary ribonuclease 60 osteoinductive 60 intranasal delivery 60 epoetin alpha 59 subcutaneous SC 59 Resten NG 59 vinorelbine tartrate 59 LymphoStat B TM 59 hapten 59 immunomodulatory therapy 59 PSMA ADC 59 TRX1 59 sd rxRNA 59 peptide conjugated 59 including eniluracil ADH 59 Factor VIIa 59 PHX# 59 ESBA# 59 plasmid DNA vaccine 59 PEGylated anti 59 Selective Electrochemical Tumor Ablation 59 XOMA 3AB 59 DURIN TM 59 #beta estradiol 59 therapeutic monoclonal antibody 59 ADP receptor antagonist 59 tumor specific antigen 59 5 HT2C receptor 59 BiTE 59 eTag assays 59 ancrod 59 Xanafide 59 adipogenic 59 HepDirect prodrug 59 oral prodrug 59 #T# L1 59 MGd 59 visilizumab 59 CorVue ™ 59 HCV polymerase 59 FVIIa 59 Hemopurifier ® 59 octreotide implant 59 Gleevec resistant 59 sodium glucose cotransporter 59 5 HT3 antagonist 59 Prodarsan R 59 AERx ® 59 ALN PCS 59 glutamic acid decarboxylase 59 murine model 59 oral PTH 59 PEGPH# 59 Chemophase 58 lyophilized formulation 58 HuLuc# 58 pegylated recombinant 58 Omacetaxine 58 BeneFIX 58 BrachySil TM 58 Tarceva TM 58 wilate ® 58 TG# [003] 58 non porcine pancreatic 58 Glucagon Like Peptide 58 beta 1a 58 Q#IR 58 XL# XL# 58 genomic biomarker 58 multiple myeloma MM 58 OvaRex R 58 Solazed 58 sitaxsentan 58 Poly ICLC 58 tumorigenicity 58 radiolabeled 58 splice variants 58 ZFP TFs 58 eniluracil 58 rFSH 58 ChronVac C R 58 anti CD3 58 PrevOnco ™ 58 Protein Kinase C 58 targeted antifolate 58 PI3K inhibitor 58 recombinant factor VIIa 58 recombinant follicle stimulating 58 Insulin PH# 58 receptor tyrosine kinase inhibitor 58 PhG alpha 1 58 tezampanel 58 CD# expressing 58 GLP1 INT TM 58 Belerofon 58 erythropoietic 58 catheter occlusion 58 HQK 58 DUROS 58 systemically administered 58 haematologic 58 ospemifene 58 synthetic analogues 58 inhibitor PPI 58 trivalent influenza vaccine 58 HuMax 58 selective agonists 58 ATL# [001] 58 novel emulsion formulation 58 EGFR HER2 58 Granulocyte Colony Stimulating Factor 58 insulin analogs 58 phage display technology 58 TRAIL R2 58 selective modulator 58 ZOLINZA 58 humanized anti 58 protein tyrosine phosphatase 1B 58 topical gel formulation 58 CIMZIA ™ 58 bFGF 58 therapeutic peptide 58 reslizumab 58 #ß 58 either acutely decompensated 58 Panzem R 57 XP# XP# 57 RhuDex ® 57 relapsed MM 57 hMG 57 Vaxfectin R adjuvant 57 Personalized Immunotherapy 57 insulin aspart 57 pegylated IFN 57 CYT# potent vascular disrupting 57 Xyfid TM 57 epothilone 57 Zolpimist ™ 57 kinase inhibition 57 CD# antibody [001] 57 histone deacetylase HDAC 57 MAXY VII 57 TKM ApoB 57 cathepsin K inhibitor 57 inhaled formulations 57 proprietary transdermal patch 57 protein tyrosine phosphatase 57 interferon IFN 57 HepaGam B 57 GLP1 agonist 57 volociximab 57 IL 1ß 57 TBC# 57 bispecific antibody 57 pegylated 57 MMP# 57 PEG IFN 57 CCR5 inhibitor 57 IV Busulfex 57 anticancer compound 57 tumor xenograft models 57 VITAL Trial 57 TNF Tumor Necrosis Factor 57 potent antiproliferative 57 NanoCrystal ® technology 57 DCCR 57 rhIGF-I/rhIGFBP-3 57 selective androgen receptor modulator 57 XL# anticancer compounds 57 non constipating irritable 57 NOD SCID mice 57 constitutively expressed 57 CIMZIA TM 57 JAK inhibitor 57 Posiphen 57 NMDA antagonist 57 IFN alpha 57 alkylating 57 2A receptor agonist 57 Decitabine 57 NeuroSTAT ® 57 Liposomal 57 selective adenosine 57 B lymphocyte 57 integrin receptor 57 Evoltra ® 57 ddRNAi 57 recombinant antibodies 57 GHRH 57 herpetic keratitis 57 ELISPOT assay 57 EP #R 57 allogeneic cell 57 human chorionic gonadotropin hCG 57 LB# [003] 57 cytotoxicity assays 57 hyperphenylalaninemia HPA due 57 adipiplon 57 factor VIIa 57 tropism testing 57 hemodynamically significant 57 L asparaginase 57 mGluR2 positive 57 ONX 57 Alferon N 57 Ostabolin C TM 57 cytidine 57 selective antagonist 57 biologic DMARD 57 GEMS TM 57 antisense oligonucleotide 57 subcutaneous immunoglobulin 57 SAR# [004] 57 Apoptone 57 5 Fluorouracil 57 Androxal TM 57 AERx iDMS 57 tumor lysate 57 Dapagliflozin 57 IAP inhibitor 57 mTOR inhibition 57 tumor antigen 57 mesalazine 57 HuMax CD4 57 MoxDuo 57 Archexin 57 INTERCEPT platelets 57 somatostatin 57 lanthanum carbonate 56 otelixizumab 56 MEK inhibitor 56 Genasense ® oblimersen 56 poly ethylene glycol PEG 56 goserelin 56 CHOP chemotherapy 56 MCF7 56 plasmin 56 Oncaspar 56 FOLFOX chemotherapy 56 pharmacophore 56 DDP# 56 lintuzumab SGN 56 NS5A 56 TransVax tm 56 EDEMA3 trial 56 daily subcutaneous injections 56 Amikacin Inhale 56 GED aPC 56 atacicept 56 acyl CoA 56 selectively binds 56 evaluating satraplatin 56 indibulin 56 picomolar 56 antisense drug 56 CCR5 antagonist 56 metaplasia 56 immunotherapeutic vaccine 56 stranded nucleic acids 56 isoenzyme 56 p# Shc 56 iobenguane 56 synthetic peptide containing 56 PI3K/Akt pathway inhibitor 56 fosbretabulin 56 CG# [003] 56 polyclonal antibody 56 humoral responses 56 opioid receptor antagonist 56 anti CD3 monoclonal 56 serum lipid 56 PDE# inhibitors 56 unmutated 56 demonstrated antitumor activity 56 mg/m2 dose 56 stimulate insulin secretion 56 pharmacodynamic markers 56 systemic hypotension 56 inhaled formulation 56 pharmacokinetic PK profile 56 oral transmucosal 56 TIMP 1 56 urinary N telopeptide 56 glulisine 56 Annexin V 56 delivery polymer matrix 56 fluoropyrimidine 56 DermaVir Patch 56 Phase IIb clinical trials 56 Myocet 56 paclitaxel poliglumex 56 phase IIb trial 56 ACUROX ® 56 Onconase 56 Moli# 56 constitutively active 56 hematological parameters 56 eIF4E 56 thrombin inhibiting aptamer 56 Phase #b/#a clinical 56 Traficet EN 56 elotuzumab 56 Tasimelteon 56 ghrelin receptor 56 omecamtiv mecarbil 56 5 HT2C 56 glutamyl 56 bispecific 56 SPRYCEL ® 56 induce remission 56 Lauriad 56 torezolid phosphate 56 Phase Ib study 56 SomatoKine 56 paclitaxel Taxol 56 CCR9 antagonist 56 TÎ ² 4 56 intracellular pH 56 EVIZON TM 56 Sanofi Pasteur Fluzone 56 developing Bicifadine serotonin 56 NurOwn ™ 56 MVax 56 Immunotherapeutic 56 vivo validation 56 Annamycin 56 prokinetic agent 56 gonadotropin releasing hormone GnRH 56 pioglitazone HCl 56 pharmacodynamic properties 56 IMP# 56 RenaZorb TM 56 ActA 56 receptor monoclonal antibody 56 Intravesical 56 P#X# 56 Arikace 56 Privigen 56 GA GCB 56 transgene expression 56 lanreotide 56 hepatoma 56 P#Y# [002] 56 Allovectin 7 56 levodopa carbidopa 56 A1PI 56 VAPRISOL 56 estrogen receptor antagonist 56 recombinant albumin 56 adrenocorticotropic hormone 56 thrombin receptor 56 microinjection 56 alpha#beta# integrin 56 Umbilical cord stem cells 56 Vaxfectin 56 replicon 56 subcutaneous implant 56 lomitapide 56 5 hmC 56 Targretin capsules 56 Ganciclovir 56 oral rivaroxaban 56 Civacir 56 GRNVAC1 56 Amino acid 56 YONDELIS 56 alpha 2A 56 somatostatin analog 56 ApoB SNALP 56 fatty acid biosynthesis 56 5alpha reductase 56 lung surfactant 56 chemosensitivity 56 AzaSite Plus 56 alpha antagonist 56 PET tracers 56 immunotoxin 56 HCV protease inhibitors 56 vascular disrupting agents 56 AMEVIVE 56 GRALISE 56 parasitemia 56 TKB# 56 Interferon gamma 56 CD#c 56 protein quantitation 56 omega interferon 56 prostate carcinoma 56 PORxin TM platforms 56 amikacin 56 ASONEP 56 dosing cohort 56 Lispro 56 GIPET 56 cetuximab Erbitux ® 56 RAPTIVA 56 C1 INH deficiency 56 Secretase 56 motexafin gadolinium 56 lipid nanoparticle 56 chemokine receptor 56 Cleviprex TM clevidipine 56 gamma amino butyric 56 NK1 56 oral taxane 56 NanoEmulsion 56 multiplexed assays 56 IntroductionThe 56 redox active 56 von Willebrand Factor 56 arsenic trioxide injection 56 TLK# 56 tumor vascular disrupting 56 small molecule tyrosine 55 tricalcium phosphate 55 Panzem ® 55 colony stimulating factor 55 HuMax EGFr 55 Chinese Hamster Ovary 55 Protexia ® 55 Saizen R 55 INCB# [001] 55 inecalcitol 55 Galectin 55 product candidate Lpathomab 55 5 HT4 receptor 55 CHO cell 55 human C1 inhibitor 55 dose cohort 55 serum aminotransferase levels 55 Phase #b/#a trial 55 dacetuzumab 55 albiglutide 55 potent CYP#A# inhibitors 55 pharmacokinetic characteristics 55 SNALP technology 55 oral nucleoside analogue 55 targeting PCSK9 55 Chemokine Receptor 55 imexon 55 Plenaxis TM 55 AZX# 55 ImmuneY2 55 treprostinil 55 Fibrin MB 55 Ventavis ® 55 SinuNase ™ 55 Dacogen decitabine 55 recombinant plasma 55 acute peripheral arterial 55 non nucleoside HCV 55 AERx Essence 55 maturation inhibitor 55 Genz # 55 human serum albumin 55 kallikrein 55 cutaneous T 55 bolus injection 55 Cellastim 55 Fc receptor 55 alvespimycin 55 bardoxolone 55 Tyrosine Kinase Inhibitor 55 ATD gel 55 proteolytic cleavage 55 inhaled treprostinil 55 Keppra XR 55 rhFVIIa 55 LEAPS TM 55 Curaxin CBLC# 55 ALN HTT 55 tubulin inhibitor 55 lispro 55 lixivaptan 55 fallopian tube cancers 55 C1 inhibitor rhC1INH 55 cromolyn sodium 55 Phase 2a clinical trials 55 immune modulatory 55 Inhalation Solution 55 synthetic siRNA 55 lactate dehydrogenase LDH 55 LANTUS R 55 LEUKINE 55 cefotaxime 55 R#/MEM # 55 biochemical relapse 55 GnRH agonist 55 Elagolix 55 Serostim ® 55 Vaxfectin R 55 oral salmon calcitonin 55 CytoFabTM 55 cellular cytotoxicity 55 oral ghrelin agonist 55 EVIZON ™ 55 Vivaglobin 55 PICM #H 55 mediated inhibition 55 Specifid 55 beta islets 55 huN# DM1 55 vernakalant hydrochloride 55 serine protease 55 alpha2 55 proprietary MSCRAMM ® 55 Neurodex TM 55 rhIGFBP 3 55 GVAX ® 55 brand ciclesonide HFA 55 PARI Pharma GmbH 55 preclinical efficacy 55 fluticasone furoate 55 theranostic 55 phosphorothioate 55 severe gastroparesis 55 sargramostim 55 Annexin A5 55 AKT inhibitor 55 PRTX 55 intranasal insulin 55 aldehyde dehydrogenase ALDH2 deficiency 55 preclinically 55 rxRNA ™ compounds 55 glycosylated 55 GLPG# 55 DEEP AF 55 adrenoceptor 55 metformin sulfonylureas 55 aspartate aminotransferase AST 55 rALLy clinical trial 55 E1 INT TM 55 Tasigna prolongs 55 cell adhesion molecule 55 Captisol ® 55 huC# DM4 55 pen injector 55 sulfonylurea metformin 55 plasma uric acid 55 ascending dose 55 systemic immunosuppressive drugs 55 immunoglobulin Ig 55 phenotypic expression 55 muscarinic 55 Plicera 55 Pyridorin 55 fluvoxamine maleate 55 Delivery System NTDDS 55 Vascular Disrupting Agent 55 metastatic malignant 55 mRNA sequences 55 PEG SN# 55 ONCONASE R 55 Aerosurf 55 Vinorelbine 55 THR beta agonist 55 recombinant biopharmaceutical 55 ELACYT 55 porcine derived 55 granisetron formulated 55 intracavitary 55 ara C 55 idiotype vaccine 55 Soliris eculizumab 55 anticancer activity 55 lesional 55 edifoligide 55 hGH CTP 55 PTH analogue 55 biphasic insulin aspart 55 PORxin TM 55 intestinal mucosal 55 radiolabelled 55 bolus dose 55 alagebrium 55 Maxy G# 55 VEGF receptor 55 triphendiol 55 BrachySil ™ 55 ZFN modified 55 metabolic inhibitor 55 Optiquel ™ 55 Silodosin 55 Cand5 55 Oral Spray 55 hyperinsulinemic euglycemic clamp 55 Amplimexon 55 ritonavir boosted 55 GlycoPEG GCSF 55 synDNA TM 55 Linjeta TM 55 Cloretazine 55 oral proteasome inhibitor 55 nasal spray formulation 55 recombinant Factor VIIa 55 intramyocardial 55 inverse agonist 55 Capesaris 55 dorzolamide 55 pharmacokinetic equivalence 55 r hGH 55 histone deacetylase 55 EmbraceAC 55 M1 muscarinic 55 MDCK 55 RRM1 55 intercellular adhesion molecule 55 siRNA duplexes 55 bronchoalveolar lavage 55 DEB# 55 faropenem medoxomil 54 beta1 54 Sufentanil 54 adecatumumab MT# 54 Major Depressive Disorder MDD 54 Enzastaurin 54 SynCon 54 MYDICAR ® 54 Diamyd R 54 trospium 54 Mycophenolate mofetil 54 MP4OX 54 Imatinib mesylate 54 multicenter Phase II 54 pharmacokinetic PK study 54 quinoline 54 lintuzumab 54 Anavex #-# 54 TELINTRA R 54 adrenocorticotropic hormone ACTH 54 μg liter 54 IFN α 54 Alequel ™ 54 recombinant tissue plasminogen 54 pancreatic alpha 54 MIC# [001] 54 MGN# 54 Urocidin 54 angiotensin analog 54 Zenvia ™ 54 MyoCell SDF 1 54 acyclovir Lauriad R 54 oral talactoferrin 54 Trofile assay 54 MDS AML 54 Triapine R 54 CTLs 54 PCA3 assay 54 posaconazole 54 SCIB1 54 chronic hemolysis 54 cyclin dependent kinase inhibitor 54 orally dosed 54 novel nucleoside analog 54 Onalta ™ 54 CCR5 mAb 54 TACI Ig 54 PPAR gamma agonists 54 gemtuzumab ozogamicin 54 selective agonist 54 Hsp# Inhibitor 54 Epirubicin 54 colorectal carcinoma 54 thyrotropin 54 novel oral anticoagulant 54 LEP ETU 54 IL# PE#QQR 54 compound ISA# 54 Zoledronic acid 54 squalamine 54 ALN HPN 54 deliver bupivacaine 54 ON #.Na 54 Degarelix 54 alpha subunit 54 orally disintegrating 54 statistically significant efficacy 54 totipotent 54 mononuclear 54 dose cyclophosphamide 54 uses eFlow Technology 54 N glycan 54 Cutanea 54 immunoglobulin G 54 Apo AI 54 hepatorenal syndrome 54 NovoLog ® Mix 54 Spiegelmer 54 vitro dissolution 54 isatoribine 54 receptor blocker 54 HIV integrase inhibitors 54 quantitative PCR qPCR 54 investigational immunotherapy 54 riociguat 54 CardioPET 54 Cathepsin S 54 colorectal adenoma 54 ghrelin antagonist 54 SEPET TM 54 physicochemical characteristics 54 Vaprisol 54 pentostatin 54 MVA MUC1 IL2 54 4mg/kg 54 dantrolene sodium 54 Medarex UltiMAb 54 non nucleoside inhibitor 54 CTAP# Capsules 54 Qutenza TM 54 metabolomic profiles 54 treat benign prostatic 54 methylnaltrexone bromide 54 subcutaneous PRO 54 p# activation 54 gastric retentive 54 registrational studies 54 capsular polysaccharide 54 monophasic 54 HepeX B 54 VP# [004] 54 patented Bioral 54 cell lysate 54 successfully commercialize Iluvien 54 topical formulation 54 CRMD# 54 piperacillin tazobactam 54 HDACi 54 dopamine partial agonist 54 alpha1 proteinase inhibitor 54 dose titration 54 opioid induced bowel dysfunction 54 lentiviral 54 DACH platinum 54 bevasiranib 54 BAL# [002] 54 XP #L 54 VBLOC TM 54 NPM1 mutation 54 GPx 54 airway epithelial 54 cGMP manufacture 54 dopamine D2 54 Intraject 54 HDL Selective Delipidation 54 oral methylnaltrexone 54 fibulin 54 serum phosphate 54 Pharmacokinetic studies 54 Hedgehog pathway inhibitor 54 microwell plate 54 DURECT proprietary 54 Aromatase 54 ATPace TM 54 Imatinib Mesylate 54 SYN# 54 eculizumab therapy 54 tolevamer 54 Onrigin TM 54 NOD mouse 54 prospectively stratified 54 CD3 monoclonal antibody 54 immunostaining 54 clonidine hydrochloride 54 neuroactive 54 poliovirus vaccine 54 inhaled AAT 54 BACcel 54 ImmuKnow R 54 CD# monoclonal antibody 54 VIAject R 54 Dual Opioid 54 budesonide foam 54 colon carcinoma 54 DPX Survivac 54 Vernakalant 54 Inhalation Powder 54 ligand receptor 54 lutropin alfa 54 virosome 54 pleiotropic 54 inhaled iloprost 54 multicenter randomized placebo controlled 54 osteoblast 54 myeloproliferative diseases 54 glyco 54 IMiDs R 54 FLT3 54 DXL# 54 HEK# 54 ND# [002] 54 Phase 1a clinical 54 delta gamma agonist 54 glomerular 54 basal insulin analogue 54 carcinoid syndrome 54 Pharmacokinetics PK 54 ISTODAX 54 Vascular Wrap TM 54 sodium glucose transporter 54 rusalatide acetate 54 intravenous dosing 54 ENaC 54 ß2 54 Carbidopa 54 syngeneic 54 OMS# 54 Recombinant Human 54 AdhTAP 54 thorough QT 54 OnDose 54 LCP Tacro TM 54 postprandial glycemia 54 assay detects 54 Microplasmin 54 Initiate Clinical Trial 54 HER2 overexpression 54 postexposure 54 5HT 54 DiLA2 liposomes 54 TPMT 54 alpha fetoprotein AFP 54 nasally delivered 54 Immunomodulatory 54 qNPA 54 HCV polymerase inhibitor 54 liver resection surgeries 54 TELINTRA 54 metformin XR 54 statistical significance p 54 QLT# 54 lamivudine resistant 54 antigen adjuvant 54 JAK2 V#F 54 beta interferons 54 delivered subcutaneously 54 5 HT3 receptor 54 cobalamin 54 pretargeting 54 osteoconductive 54 multi analyte 53 NPH insulin 53 BioMarck 53 nonclinical studies 53 AERx R 53 sub maximal 53 concurrent chemoradiation 53 Mipomersen 53 vitro ADME 53 Dynabeads 53 mimetics 53 p# inhibitor 53 OMNARIS Nasal Spray 53 cannabinor 53 systemic RNAi 53 opioid bowel dysfunction 53 Methylnaltrexone 53 bioscavenger 53 Bicifadine 53 Alvesco R 53 FOLOTYN ® 53 aggregated Abeta 53 Ii Key 53 zinc cysteine 53 QuadraSphere 53 microRNA profiling 53 MKC# MKC# PP 53 hoFH 53 EOquin 53 ritonavir boosted protease inhibitor 53 trastuzumab DM1 T DM1 53 IMC A# 53 phosphoprotein 53 Cefazolin 53 VSV G 53 maturation inhibitors 53 MALDI-TOF/TOF 53 human chorionic gonadotrophin 53 NP2 Enkephalin 53 anterior pituitary 53 microsomal 53 UCOE 53 peripherally acting 53 PolyHeme ® 53 omacetaxine mepesuccinate 53 SSc 53 HP hMG 53 Phase IIb III 53 lysophosphatidic acid 53 recombinant insulin 53 deoxy 53 Zavesca R 53 ACAPODENE 53 BIO SET 53 BENLYSTA ® 53 TNFalpha 53 p# antigen 53 interleukin IL 53 #mg/day [002] 53 Captisol enabled 53 Technosphere ® 53 triacylglycerol 53 selective A2A adenosine receptor 53 Dacogen injection 53 E selectin 53 Mg Usa 53 nanomolar 53 NovoMix ® 53 Mutation Analysis 53 bladder carcinoma 53 adrenocortical 53 zileuton 53 solubilization 53 JAK3 53 remission induction 53 hydroxylase 53 glucosylceramide 53 DOS# 53 Nebulizer System 53 Medoxomil